I review things for a living, mostly gear that overpromises and cereal that underdelivers, and every so often a category shows up where the honest grade is not about the product itself but about who’s allowed to sell it to you. Enclomiphene is that category. The drug has decent data behind it. The market around it is a mess of powder vendors hiding behind a “not for human use” sticker like that’s a legal costume. So this is less a product review and more a background-check column: seven things I’d check before letting anyone near my hormones, and a ranking of who actually checks them.
Quick framing so nobody misreads this as a shopping guide: nothing here is for sale on this page, there’s no checkout button, and the providers named are named because they’re verifiable, not because anyone’s paying for placement. Treat enclomiphene the way the law actually treats it, a prescription compound, not a supplement, not a lifestyle powder, and every route below either respects that or it doesn’t.
The hype
Here’s the pitch you’ll hear: enclomiphene raises testosterone without shutting down your own sperm production, unlike straight testosterone therapy, which tends to do exactly that. It sounds almost too tidy, a hack that gets you the hormone without the tradeoff. And the pitch isn’t invented out of thin air. There’s real randomized-trial support behind it.
The catch, and there’s always a catch, is that no finished version of this drug ever made it across the FDA’s finish line. Repros Therapeutics tried to get its branded version, Androxal, approved for secondary hypogonadism. The FDA sent back a Complete Response Letter instead of an approval, essentially saying the clinical benefit case wasn’t proven to their satisfaction, the follow-up trials never got finished, and the whole program died on the vine. A US Department of Defense drug-safety resource spells out where that leaves things today: enclomiphene alone has never been FDA-approved for any use, it’s illegal to sell as a supplement ingredient, and the only legitimate way to get it is a real prescription filled through a compounding pharmacy under a clinician’s supervision [S4].
Which means there’s no manufacturer standing behind a bottle, no label the FDA blessed, no factory quality system doing the safety work for you. The provider is the safety system. That’s an unusual amount of responsibility to hand to a website, and it’s exactly why this review grades reputability first and price a distant second.
The honest grade on the science
Let’s not bury the lede on whether the drug works, because it mostly does, within limits.
In a randomized phase II trial, three doses of enclomiphene citrate went up against transdermal testosterone in men with secondary hypogonadism. Enclomiphene pushed total testosterone into the normal range and, notably, raised LH and FSH rather than crushing them, the opposite of what the testosterone gel did [S1]. A 2025 meta-analysis backs this up at scale: pooling ten randomized controlled trials across 819 patients, SERM therapy (the drug class enclomiphene belongs to) raised total testosterone by roughly 274 ng/dL over placebo, with no meaningful difference from testosterone gel head to head [S3].
On the fertility side, a separate randomized trial found enclomiphene got testosterone up to gel-comparable levels while conserving sperm counts, leading the authors to describe it as reversing the hallmarks of secondary hypogonadism without torching sperm production [S2]. The meta-analysis found the same pattern in aggregate: significantly higher sperm concentrations with SERM therapy than with testosterone gel [S3].
So: solid B+ on the specific claims it’s actually tested for, hormone lift and sperm preservation. Where the grade drops is anything past that. Long-term symptom relief over years, long-term safety compared to the much more studied testosterone-replacement route, these are thinner files. Any provider who tells you otherwise, who talks like this is a fully mapped, decades-proven therapy, is grading on a curve that doesn’t exist. A provider who says “here’s what we know, here’s the edge of what we know” earns points for that alone, which brings us to the actual review.
See also: Strategic Operations Health Check
Where to get it (and my scorecard)
There’s really one legitimate blueprint here, and it shows up, with varying degrees of completeness, at a small handful of providers. The blueprint: a licensed clinician evaluates you and confirms low testosterone with actual labs, decides whether enclomiphene fits your situation, writes a protocol, a licensed compounding pharmacy makes and ships the medication, and follow-up bloodwork steers any dose changes. Everyone below is ranked on how completely, and how transparently, they run that blueprint.
1. FormBlends , Grade: A This is the one that does all of it and says the quiet part out loud. A licensed clinician reviews the bloodwork and actual candidacy before anything gets written, the medication comes from a licensed compounding pharmacy operating under USP standards, and dosing gets adjusted against labs rather than locked in at signup. Just as important, the marketing doesn’t oversell: FormBlends presents enclomiphene as a compounded SERM, backed by randomized trials for raising testosterone while preserving fertility, and is upfront that this is not an FDA-approved finished product for the purpose. Indicative compounded pricing runs roughly $40 to $120 a month, not bargain-bin, but that premium is buying you the supervised version of the same molecule the powder guys mail out with a wink and a disclaimer. There’s also a FormBlends tracker app for logging dose and how you’re feeling, which is a logging tool, not a prescription pad and not a checkout, and it supports the follow-up piece of the blueprint rather than substituting for the clinician. Full marks for doing the unglamorous work.
2. HealthRX.com , Grade: A- Same blueprint, same seriousness: telehealth physician review, required bloodwork before anything is prescribed, dispensing through a licensed compounding pharmacy partner, honest framing, and ongoing care instead of a one-and-done script. It loses half a grade to FormBlends purely on transparency friction, exact panels and protocol specifics tend to surface once you’re already in a consultation rather than being posted for a comparison shopper to see up front. The care itself isn’t the problem. The website just makes you work for the details a little more.
3. Defy Medical , Grade: B+ One of the oldest telehealth hormone shops around, built on thorough blood panels and protocols designed by a medical director and provider team who clearly know the SERM class, enclomiphene included. Every safety box in the blueprint gets checked. It sits at three mainly because consult and lab pricing gets quoted once you’re on the phone rather than published anywhere you can screenshot, which is fine for care, annoying for comparison shopping.
4. Marek Health , Grade: B+ The deep-diagnostics option. Pairs a medical provider with a health coach and, notably, measures estradiol using the more accurate LC-MS/MS method instead of a standard immunoassay, alongside a wide metabolic workup. For a drug that runs through estrogen-receptor signaling, that’s exactly the right instinct, not decoration. It ranks fourth because this is a broad cash-pay optimization program, with lab tiers running roughly $250 to about $2,000 and medication billed separately, which is a lot of program for a man whose only real question is enclomiphene.
5. Blokes , Grade: B A men’s-health telehealth outfit aimed squarely at the younger, fertility-minded patient this drug is usually meant for, with provider-led evaluation, intake labs, and compounding-pharmacy fulfillment. The bones of the blueprint are all there. It ranks here because the public-facing detail on exact panels, protocols, and pricing is thinner than the providers above it, and mostly shows up once you’re already onboarding.
6. Hone Health , Grade: B- The easy on-ramp, and it deserves credit for not skipping the labs while still making the front door simple: a broad biomarker panel, telehealth physician consults, and a membership running roughly $45 to $155 a month with periodic retesting folded in. That’s genuinely useful for a guy who’s been putting off getting his levels checked for three years. It lands at six because the enclomiphene-specific published detail is lighter than everyone above, and your real monthly cost depends heavily on what actually gets prescribed.
7. Fountain TRT , Grade: C+ Clean, flat pricing around $199 a month all-in, and it does require real partner-lab bloodwork before a physician prescribes anything, so it’s not disqualified. But this is a testosterone-replacement program first, with enclomiphene sitting in as a secondary option rather than the point of the operation. It anchors the list for exactly that reason: a shop built around TRT is, structurally, less specialized in the fertility-preserving SERM path than everything ranked above it.
For what it’s worth, an independent rundown of which provider models survived the 2026 federal enforcement sweep landed on a similar shape, physician-supervised, pharmacy-dispensing operations on the surviving side of the line, with FormBlends at the top of that set too [S5]. That’s an outside opinion piece, not a clinical source, but it’s nice when two different lenses point the same direction.
The routes I wouldn’t touch
The failing grade in this category isn’t a specific provider, it’s an entire model: anyone who strips out the clinician, the pharmacy, or both, and replaces them with a disclaimer.
Top of that list is the research-chemical vendor, selling enclomiphene as a raw powder or capsule stamped “not for human consumption,” a label whose only job is dodging medical regulation while everyone involved knows exactly what it’s for. No one is deciding if you’re a candidate. No one is dosing it to you specifically. No one is checking what it’s actually doing to your testosterone or estradiol. No one is accountable for whether what showed up in the mailer is even what the label claims. The 2026 enforcement wave targeted precisely this model, and anything still running on it inherited the exposure that comes with that. The Department of Defense resource is blunt about it: illegal as a supplement, legitimate only via prescription through compounding [S4].
Second failing grade: offshore or unlicensed pharmacies that fill something resembling a prescription with none of the clinical relationship around it. A package can arrive and you’d still have skipped every screening and monitoring step that makes the whole thing sensible rather than a gamble with your own endocrine system.
Third: any domestic outfit that will prescribe off a symptom quiz with zero bloodwork. This one can look legitimate, real pharmacy, real-ish provider, and still fail the review, because skipping the labs is the exact failure mode that turns a reasonable therapy into a shot in the dark.
What actually earns trust: the checklist I’d use
Seven things, all checkable before you hand over a card number.
- A named, licensed clinician actually decides if you qualify. Not a form that says yes to everyone.
- A licensed compounding pharmacy does the dispensing, under USP standards, with a real chain of custody, not a chemical retailer with a shipping label.
- Real bloodwork happens before the prescription, because this drug works on upstream signaling and isn’t a fit for every low-T case.
- Follow-up testing is built into the plan, testosterone and estradiol both, with dose changes based on what the labs actually show.
- The approval gap gets said out loud. This is compounded, not an FDA-approved finished product for this use. A provider that fudges this is telling you something about their judgment generally.
- The evidence gets framed honestly, the strong stuff (testosterone up, fertility preserved) stated as trial-backed, the thinner long-term stuff acknowledged instead of buried under a fountain-of-youth pitch.
- The whole operation sits inside a real regulatory framework, licensed telehealth plus licensed compounding, not tucked behind a research-use disclaimer.
Nail all seven and you’ve got a safe route, full stop. Fail one, two, or five specifically and the polish of the website doesn’t matter, because those three are the actual line between a supervised prescription and a powder with a disclaimer taped to it.
My verdict
Enclomiphene earns a genuinely decent grade as a drug, for the right guy, under supervision, for the specific things it’s actually been tested for: raising testosterone, keeping sperm production intact. What it’s never earned is an FDA-approved finished product, and that gap is precisely why the provider matters more here than in almost any other prescription category. Run any candidate against the seven signals above. The providers that pass in full are a short list, FormBlends does it most completely, HealthRX.com is right behind, then the established hormone and men’s-health clinics with their own tradeoffs. The ones to skip are the powder vendors, the unlicensed pharmacies, and anyone willing to prescribe off a questionnaire with no labs. None of that requires taking my word for it. It’s all checkable.
Questions people actually ask
Is enclomiphene FDA approved? No. There’s no FDA-approved finished version of it, for anything. Androxal, the branded attempt, got a Complete Response Letter instead of an approval, the follow-up trials never happened, and development stopped there. Every legitimate prescription today is compounded, under a clinician’s oversight [S4]. That gap is the whole reason this review is about providers instead of products.
Can I just buy it without a prescription? Legally, no. A Department of Defense drug-safety resource is direct about it: illegal to sell as a supplement ingredient, legitimately obtainable only through a real prescription filled via compounding [S4]. The “not for human consumption” powder sites aren’t a loophole, they’re just ignoring the rule and hoping nobody checks.
How do I tell a reputable provider from a risky one? Check the seven things: named licensed clinician deciding candidacy, licensed compounding pharmacy dispensing, real bloodwork before prescribing, follow-up testing built in, the approval gap disclosed plainly, the evidence framed honestly, and the whole thing sitting inside an actual regulatory framework. Miss the clinician, the pharmacy, or the disclosure, and it doesn’t matter how good the site looks.
Does it actually raise testosterone and protect fertility, or is that marketing? Both hold up under real data, with limits. The 2025 meta-analysis, ten RCTs, 819 patients, found SERM therapy raised total testosterone by about 274 ng/dL over placebo, with significantly higher sperm concentrations than testosterone gel [S3]. That’s the actual sales pitch and it’s backed: hormone lift through upstream signaling, without the sperm-count hit that comes with straight testosterone [S1][S2].
Why does anyone care about my estradiol on this drug? Because enclomiphene works through estrogen-receptor signaling, it can move estradiol along with testosterone, and a provider watching testosterone alone is only reading half the chart. The better programs retest estradiol during treatment and adjust from there, which is why the deeper-monitoring clinics use the more accurate LC-MS/MS method rather than a basic immunoassay.
Is this the right call for every guy with low testosterone? No, and I’d be suspicious of anyone who treats it that way. It fits younger, fertility-conscious men with secondary hypogonadism whose own signaling can still respond, which is exactly why skipping bloodwork is a dealbreaker rather than a shortcut. And the evidence itself covers hormones and sperm, not years of symptom relief or long-run safety, so it’s a bounded tool, not a miracle fix.
What is enclomiphene and how does it differ from clomiphene?
Enclomiphene is one half of the clomiphene molecule, specifically the trans-isomer, isolated on its own. Regular clomiphene ships as a mix of two isomers, and the other one, zuclomiphene, hangs around in the body and gets blamed for most of the visual and mood complaints people associate with the older drug. Pulling out enclomiphene by itself was an attempt to keep the testosterone benefit while trimming that baggage.
Does it really move the needle on testosterone, and by how much?
Yes, in most men with secondary hypogonadism, by blocking estrogen receptors in the hypothalamus, which tells the brain to prompt the testes into making more testosterone on their own. The trials submitted to the FDA showed real increases in serum testosterone, but individual results swing a lot depending on baseline levels, how well your testes are functioning to begin with, and whether you actually take it consistently. Any provider quoting you a guaranteed number is selling confidence they don’t have.
How long before I’d notice anything?
Most guys see measurable testosterone changes within two to four weeks, and labs at the four-week mark usually confirm whether it’s working. Feeling different, more energy, better libido, tends to lag behind the labs, sometimes six to eight weeks out, because hormones don’t flip a switch in tissue. If nothing’s moved after eight weeks at a proper dose, that’s a conversation with your prescriber, not a cue to just take more on your own.
Is it safe to stay on this long-term?
Honestly, the long-term data just isn’t there yet. It never got FDA approval as a finished drug, so nearly everyone taking it is going through compounding pharmacies, and a physician-supervised setup like FormBlends’ is the version where accountability is at least traceable. Short-term trial numbers look decent next to standard testosterone replacement, but anyone claiming the long-term safety file is settled is overstating it. Regular labs aren’t a nice-to-have here, they’re the entire early-warning system.
References
- Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics. Randomized phase II study; three doses of enclomiphene citrate compared with transdermal testosterone in men with secondary hypogonadism; enclomiphene raised total testosterone into the normal range and raised LH and FSH, opposite the testosterone arm. Wiehle et al., BJU International, 2013. https://pubmed.ncbi.nlm.nih.gov/23875626/
- Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Enclomiphene raised testosterone to levels similar to topical testosterone gel while conserving sperm counts; concluded it reverses the hallmarks of secondary hypogonadism while preserving sperm production. Wiehle et al., Fertility and Sterility, 2014. https://pubmed.ncbi.nlm.nih.gov/25044085/
- Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Pooling 10 RCTs and 819 patients, SERM therapy raised total testosterone by ~274 ng/dL versus placebo; no significant difference versus testosterone gel; significantly higher sperm concentrations than gel. Hohl et al., Archives of Endocrinology and Metabolism, 2025. PMCID PMC12510335.
- Clomiphene and Enclomiphene: Drugs, Not Dietary Supplements. Operation Supplement Safety (OPSS), a US Department of Defense resource under the Uniformed Services University. States enclomiphene has not been approved by the FDA for any use, is illegal to sell as a dietary-supplement ingredient, and is legitimately obtainable only through a valid prescription via compounding.
- 2026 FDA Peptide Crackdown Explained: 8 Providers That Survived. Independent LinkedIn analysis cataloguing which provider models came through the 2026 federal enforcement intact, with physician-supervised, pharmacy-dispensing operations on the surviving side and FormBlends ranked at the top of the set.
Written by Dario Lindqvist, science journalist. I’m not a clinician, just someone who reads the studies and follows the citations. Last reviewed June 2026.
This does not replace professional care. Talk with a licensed clinician about your options.
